OpenLegislation

Paragraph 8 The Medicines for Human Use (Clinical Trials) Regulations 2004I1

England and Wales

(1)

The Medicines for Human Use (Clinical Trials) Regulations 2004f1 are amended as follows.

(2)

In regulation 2(1) (interpretation), in the definition of “health service body”—

(a)

in paragraph (b), after “Primary Care Trust” insert “, clinical commissioning group”; and

(b)

after paragraph (b) insert—

“(ba)

the National Health Service Commissioning Board,”.

(3)

In Schedule 2 (additional provisions relating to Ethics Committees)—

(a)

in paragraph 3(5)(b)(iii), at the end of paragraph (bb) insert—

“; or

(cc)

the governing body of a clinical commissioning group”; and

(b)

in paragraph 6(6)(a)(ii), after “health service body” insert “or the governing body of a clinical commissioning group”.

Annotations

Commencement

I1

Sch. 3 para. 8 in force at 1.10.2012, see art. 1(2)(b)

Footnotes

f1

S.I. 2004/1031. Relevant amending instruments are S.I. 2006/562, S.I. 2008/941 and S.I. 2011/2581.